Labcorp (LH) Receives FDA De Novo Marketing Authorization for PGDx elio plasma focus Dx

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Labcorp (LH) Receives FDA De Novo Marketing Authorization for PGDx elio plasma focus Dx

Laboratory Corporation of America (LH) PT Raised to $260 at BofA Securities

August 5, 2024 5:41 AM EDT

BofA Securities analyst Derik de Bruin raised the price target on Laboratory Corporation of America (NYSE: LH) to $260.00 (from $240.00) while maintaining a Buy rating.

The analyst comments "Much of the call focused on LCD margin dynamics, including Invitae contribution. Core LCD is executing... More